KalVista Pharmaceuticals (KALV) Shares Issued (2018 - 2024)
Historic Shares Issued for KalVista Pharmaceuticals (KALV) over the last 7 years, with Q4 2024 value amounting to $295000.0.
- KalVista Pharmaceuticals' Shares Issued rose 13046.88% to $295000.0 in Q4 2024 from the same period last year, while for Apr 2025 it was $99.6 million, marking a year-over-year increase of 301.63%. This contributed to the annual value of $55.9 million for FY2025, which is 4232.71% down from last year.
- Latest data reveals that KalVista Pharmaceuticals reported Shares Issued of $295000.0 as of Q4 2024, which was up 13046.88% from $3.0 million recorded in Q3 2024.
- Over the past 5 years, KalVista Pharmaceuticals' Shares Issued peaked at $96.3 million during Q2 2024, and registered a low of $46000.0 during Q3 2020.
- Moreover, its 3-year median value for Shares Issued was $249500.0 (2023), whereas its average is $16.7 million.
- Per our database at Business Quant, KalVista Pharmaceuticals' Shares Issued tumbled by 9959.73% in 2020 and then surged by 137058.82% in 2024.
- Quarter analysis of 3 years shows KalVista Pharmaceuticals' Shares Issued stood at $46000.0 in 2020, then skyrocketed by 178.26% to $128000.0 in 2023, then skyrocketed by 130.47% to $295000.0 in 2024.
- Its Shares Issued was $295000.0 in Q4 2024, compared to $3.0 million in Q3 2024 and $96.3 million in Q2 2024.